Skip to main content
You have permission to edit this article.
Edit

LATEST

Loading scores…

ALERT

Oklahoma congressional members express support for ruling against Johnson & Johnson in connection with opioid crisis

  • Updated
  • 1 min to read
James Lankford (copy)

Sen. James Lankford, R-Okla., talks with a reporter in the OU Innovation Hub April 4, 2018.

Members of Oklahoma’s congressional delegation voiced support for the recent ruling against drug manufacturer Johnson & Johnson regarding the state's opioid crisis. 

Sen. James Lankford, R-Okla., said in a statement that the ruling is a step in the right direction.

“For victims of the opioid crisis and their families, today is a day of justice,” Lankford said in the statement. “I applaud the attorney general and his team for their tireless work on behalf of every community in our state impacted by drug abuse and addiction. We must continue to address the national emergency of opioids and other drugs and work to find solutions at the federal, state, and local levels.”

Rep. Kendra Horn, D-Okla., also released a statement.

“The court confirmed what we have long known: the opioid epidemic is one of the largest public health crises our state has faced in a generation,” Horn said in the statement. “I will continue my work to hold companies accountable and bring mental health and addiction resources home to those who need them.”

Johnson & Johnson said in a press release that the company plans to appeal the decision and is confident in its grounds for appeal. The company also faces a federal trial that is set to begin in October. 

OU Daily standards

See an error? Earning trust is our duty. We correct errors atop stories. Identify an error, request a takedown or get in touch.

Independent and free since 1916: OU is committed to our editorial independence. You can help ensure our reporting remains strong and accessible to all invested in OU and Norman.

Artificial intelligence: The Daily in its news coverage does not publish reporting, writing, graphics or designs generated by AI. Read our policy.

Want to comment? We value dialogue on issues we cover. On our social media accounts, we moderate attacks, slurs, dehumanizing language, threats or the disclosure of private info. The editor considers guest column submissions.